(Q44638089)

4 December 2017

title

Immunogenicity of combined hepatitis A and B vaccine in elderly persons (English)

1 reference

4 December 2017

1 reference

1 reference

Bernd Wolters

1

1 reference

4 December 2017

Ulrich Junge

series ordinal

2

1 reference

4 December 2017

Stefan Dziuba

series ordinal

3

1 reference

4 December 2017

Michael Roggendorf

series ordinal

4

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

4 December 2017

1 reference

4 December 2017

volume

21

1 reference

4 December 2017

issue

25-26

1 reference

4 December 2017

page(s)

3623-3628

1 reference

Incidence and risk factors for acute hepatitis B in the United States, 1982-1998: implications for vaccination programs

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900399-2

7 January 2021

The first combined vaccine against hepatitis A and B: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900399-2

7 January 2021

Immunogenicity and safety in adults of hepatitis A virus vaccine administered as a single dose with a booster 6 months later

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900399-2

7 January 2021

Assessment of long-term efficacy of hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900399-2

7 January 2021

Antibody-response to three recombinant hepatitis B vaccines: comparative evaluation of multicenter travel-clinic based experience

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900399-2

7 January 2021

A prospective, randomized, comparative US trial of a combination hepatitis A and B vaccine (Twinrix) with corresponding monovalent vaccines (Havrix and Engerix-B) in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900399-2

7 January 2021

Hepatitis A and hepatitis B vaccinations: immunogenicity of combined vaccine and of simultaneously or separately applied single vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900399-2

7 January 2021

Acute hepatitis A despite regular vaccination against hepatitis A and B

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900399-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900399-2

1 reference

7 January 2021

Prevalence of markers for hepatitis A, B and C in the German population. Results of the German National Health Interview and Examination Survey 1998

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900399-2

7 January 2021

The response of isolated anti-HBc positive subjects to recombinant hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900399-2

7 January 2021

Response to hepatitis B vaccine of persons positive for antibody to hepatitis B core antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900399-2

7 January 2021

Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900399-2

7 January 2021

Long-term persistence of anti-HBs after vaccination with a recombinant DNA yeast-derived hepatitis B vaccine: 8-year results

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900399-2

7 January 2021

Four-year experience with a recombinant hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900399-2

7 January 2021

Travel vaccines and elderly persons: review of vaccines available in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900399-2

7 January 2021

Immunogenicity of two recombinant hepatitis B vaccines in older individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900399-2

7 January 2021

Hepatitis B virus vaccination for older adults

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900399-2

7 January 2021

Hepatitis-B Vaccination in the Elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900399-2

7 January 2021

Immunogenicity of standard and low dose vaccination using yeast-derived recombinant hepatitis B surface antigen in elderly volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900399-2

7 January 2021

The effect of age and weight on the response to formalin inactivated, alum-adjuvanted hepatitis A vaccine in healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900399-2

7 January 2021

Immunogenicity of recombinant hepatitis B vaccine in dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900399-2

7 January 2021

Failure of vaccination against hepatitis B with Gen H-B-Vax-D in immunosuppressed heart transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900399-2

7 January 2021

[Inoculation failure following hepatitis B vaccination. The effect of additional vaccinations]

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900399-2

7 January 2021

10.1016/S0264-410X(03)00399-2

Identifiers

DOI

1 reference

4 December 2017

1 reference